Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norberto Perico

Showing results (11-20 of 202) with videos related to

Pageof 21
Sort By:
Annals of Nutrition & Metabolism|June 20, 2015
Acute Kidney Injury in Poor Countries Should No Longer Be a Death Sentence: The ISN '0 by 25' ProjectNorberto Perico, Giuseppe Remuzzi
Clinical Nephrology|March 1, 2015
Need for chronic kidney disease prevention programs in disadvantaged populationsNorberto Perico, Giuseppe Remuzzi
The Lancet. Child & Adolescent Health|September 1, 2018
Addressing acute kidney injury in critically ill newborn babiesNorberto Perico, Giuseppe Remuzzi
The Lancet. Global Health|August 9, 2014
Chronic kidney disease in sub-Saharan Africa: a public health priorityNorberto Perico, Giuseppe Remuzzi
The Lancet. Infectious Diseases|October 29, 2022
Full-dose NSAIDs at the first sign of respiratory infection? - Authors' replyPiero Ruggenenti, Norberto Perico, Giuseppe Remuzzi
Nephron|September 20, 2016
Should We Still Believe in Randomized Controlled Trials in Nephrology?Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi
Current Opinion in Pharmacology|May 9, 2017
ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal diseaseNorberto Perico, Piero Ruggenenti, Giuseppe Remuzzi
Kidney International|April 5, 2003
Preventing end-stage renal disease: the potential impact of screening and intervention in developing countriesArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
Current Opinion in Nephrology and Hypertension|December 12, 2018
The incessant search for renal biomarkers: is it really justified?Luca Perico, Norberto Perico, Ariela Benigni
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2004
From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapyDario Cattaneo, Norberto Perico, Giuseppe Remuzzi
Pageof 21

Showing results (11-20 of 202) with videos related to

Sort By:
Pageof 21
Annals of Nutrition & Metabolism|June 20, 2015
Acute Kidney Injury in Poor Countries Should No Longer Be a Death Sentence: The ISN '0 by 25' ProjectNorberto Perico, Giuseppe Remuzzi
Clinical Nephrology|March 1, 2015
Need for chronic kidney disease prevention programs in disadvantaged populationsNorberto Perico, Giuseppe Remuzzi
The Lancet. Child & Adolescent Health|September 1, 2018
Addressing acute kidney injury in critically ill newborn babiesNorberto Perico, Giuseppe Remuzzi
The Lancet. Global Health|August 9, 2014
Chronic kidney disease in sub-Saharan Africa: a public health priorityNorberto Perico, Giuseppe Remuzzi
The Lancet. Infectious Diseases|October 29, 2022
Full-dose NSAIDs at the first sign of respiratory infection? - Authors' replyPiero Ruggenenti, Norberto Perico, Giuseppe Remuzzi
Nephron|September 20, 2016
Should We Still Believe in Randomized Controlled Trials in Nephrology?Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi
Current Opinion in Pharmacology|May 9, 2017
ACE and SGLT2 inhibitors: the future for non-diabetic and diabetic proteinuric renal diseaseNorberto Perico, Piero Ruggenenti, Giuseppe Remuzzi
Kidney International|April 5, 2003
Preventing end-stage renal disease: the potential impact of screening and intervention in developing countriesArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
Current Opinion in Nephrology and Hypertension|December 12, 2018
The incessant search for renal biomarkers: is it really justified?Luca Perico, Norberto Perico, Ariela Benigni
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 14, 2004
From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapyDario Cattaneo, Norberto Perico, Giuseppe Remuzzi
Pageof 21